Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AGGF1 Antikörper

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch AGGF1 in WB, IP, IHC (fro), IHC (p) und EIA. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN1105264

Kurzübersicht für AGGF1 Antikörper (ABIN1105264)

Target

Alle AGGF1 Antikörper anzeigen
AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))

Reaktivität

  • 41
  • 29
  • 9
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 63
  • 6
Kaninchen

Klonalität

  • 66
  • 4
Polyklonal

Konjugat

  • 46
  • 6
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser AGGF1 Antikörper ist unkonjugiert

Applikation

  • 65
  • 29
  • 25
  • 17
  • 16
  • 13
  • 13
  • 6
  • 6
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
  • Spezifität

    The antibody reacts with human VG5Q, a 84 kDa protein.

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Protein A

    Immunogen

    VG5Q functions as an angiogenic factor in promoting angiogenesis and suppression of VG5Q expression inhibits vessel formation. Angiogenic factors are critical to the initiation of angiogenesis and maintenance of the vascular network. Angiogenesis has an essential role in pathological conditions such as cancer and various ischaemic and inflammatory diseases. VG5Q can bind to endothelial cells and promote cell proliferation, suggesting that the protein may act in an autocrine fashion. VG5Q interacts with TWEAK (also known as TNFSF12), another secreted angiogenic factor. VG5Q shows strong expression in blood vessels and is secreted when vessel formation is initiated. VG5Q protein was detected mostly in the cytoplasm and around the nuclei of human microvascular endothelial cells (HMVECs). Furthermore VG5Q is detected in human umbilical vein endothelial cells (HUVECs), human heart fibroblast (HHF) and ovarian cancer cells (OV-3), but low expression was detected in kidney cancer cells (RP-45), HeLa Cells and bladder cancer cells.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C.
  • Target

    AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))

    Andere Bezeichnung

    AGGF1 / VG5Q

    Hintergrund

    Synonyms: Angiogenic factor VG5Q, Angiogenic factor with G patch and FHA domains 1, G patch domain-containing protein 7, GPATC7, GPATCH7, Vasculogenesis gene on 5q protein

    Gen-ID

    55109

    NCBI Accession

    NP_060516

    UniProt

    Q8N302
Sie sind hier:
Chat with us!